Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 3.58 | 6.86 | 7.93 | 8.65 | 3.19 |
| Operating profit | -23.72 | -14.87 | -14.52 | -14.48 | -22.16 |
| Interest | 0.04 | 0.09 | 0.17 | 0.23 | 0.30 |
| Gross profit | -15.80 | -4.18 | -14.04 | -14.45 | -17.41 |
| EPS (Rs) | -0.86 | -0.01 | -0.77 | -1.15 | -1.53 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 7.97 | 10.78 | 0.64 | 0.26 | 5.06 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 9.89 | 8.75 | 8.56 | 9.16 | 8.30 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | -14.87 | 14.87 |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 17.41 | 12.98 | 13.89 | 28.84 | 2.18 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.94 | 3.39 | 3.20 | 2.32 | 2.07 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -18.74 | -0.12 | -11.25 | -16.77 | -19.48 |
| Extra ordinary item | - | 7.46 | 6.00 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 21.81 | 21.81 | 14.54 | 14.54 | 12.73 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -662.87 | -216.85 | -183.15 | -167.32 | -694.70 |
| GPM (%) | -136.83 | -23.71 | -163.93 | -162.10 | -211.04 |
| NPM (%) | -162.31 | -0.66 | -131.26 | -188.18 | -236.12 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis